Eagle Point Income Company (EIC) Q4 2025 earnings summary

Executive summary

• 2025 saw challenging CLO market conditions, with negative total return and GAAP ROE, driven by lower SOFR, loan spread compression, and negative credit sentiment.

• Focus remains on generating high current income and capital appreciation by investing primarily in junior debt tranches of CLOs, with up to 35% in CLO equity tranches.

• Managed by a specialized team with deep CLO market experience and $14 billion AUM across the Eagle Point platform.

• Active portfolio management included rotating out of underperforming CLO managers and increasing exposure to alternative credit assets.

• Share repurchases and capital structure optimization were prioritized to enhance shareholder value, including redemption of high-cost preferred stock and securing a new revolving credit facility.

Financial highlights

• GAAP return on equity for 2025 was -0.7%; total return on common stock was -15.2% with distributions reinvested.

• Q4 2025 GAAP Net Investment Income was $0.35 per share, down from $0.39 in Q3; Q4 GAAP net loss was $14.6 million ($0.60 per share), driven by $15.6 million in unrealized losses and $7.7 million in realized losses.

• NAV per share declined to $13.31 at year-end from $14.21 at September-end.

• Paid $1.98 per share in cash distributions, representing 15% of average stock price; recurring cash flows rose 18% quarter-over-quarter to $19 million ($0.79 per share).

• Portfolio weighted average effective yield was 10.62% in Q4 2025.

Outlook and guidance

• Management expects healthy borrower fundamentals and disciplined strategy to position the company well for 2026.

• Monthly distributions of $0.11 per share declared for Q2 2026, consistent with Q1 and reflecting a 12.1% distribution rate.

• Robust pipeline of CLO refinancings and resets expected to lower liability costs.

• Positioned to capitalize on market volatility with $84.6 million in cash and credit facility capacity as of January 31, 2026.

• Emphasizes proactive sourcing, methodical analysis, and ongoing risk management to outperform the CLO market long-term.